• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

May 24, 2021
Company Drug/Device Medical Condition Status
COVID-19 Trials and Actions
Laurent Pharmaceuticals LAU-7b hospitalized patients with COVID-19 recruitment complete in phase 2 trial
Kintor Pharmaceutical proxalutamide hospitalized patients with COVID-19 approval received from the FDA to proceed with a phase 3 trial
LabCorp Pixel COVID-19 PCR test home collection kit for ages two to 17 COVID-19 test Emergency Use Authorization (EUA) granted by the FDA
Roche Cobas SARS-CoV-2 test asymptomatic COVID-19 testing EUA granted by the FDA
Other Trials and Actions
GammaDelta Therapeutics GDX012 hematological malignancies IND approved by the FDA
ImmunityBio m-ceNK platform combined with Anktiva (N-803) locally advanced or metastatic solid tumors IND approved by the FDA
DiaMedica DM199 (recombinant human tissue kallikrein-1or KLK1) acute ischemic stroke IND approved by the FDA for a phase 2/3 trial
PharmaTher Holdings ketamine levodopa-induced dyskinesia in patients with Parkinson’s disease IND approved by the FDA for a phase 2 trial
Propella Therapeutics PRL-02 (abiraterone decanoate) metastatic prostate cancer IND approved by the FDA
InnoCare oral ICP-332 autoimmune diseases IND approved by China's National Medical Products Administration
Altasciences

SiteOne Therapeutics
ST-2427 management of moderate-to-severe pain initiation of phase 1 trial
Crescendo Biologics CB307 patients with advanced and/or metastatic PSMA-positive solid tumors first patient enrolled in phase 1 trial
GoldFinch Bio GFB-024 severe insulin-resistant diabetic nephropathy first patients dosed in phase 1 trial
Mustang Bio

City of Hope
MB-101 (autologous IL13R?2-CAR T cells) leptomeningeal brain tumors (e.g., glioblastoma, ependymoma or medulloblastoma) first patients dosed in phase 1 trial
Pyramid Biosciences PBI-100 mild-to-moderate psoriasis first patients dosed in phase 1 trial
Catalyst Biosciences marzeptacog alfa (activated); MarzAA bleeding in FVII deficiency, Glanzmann thrombasthenia and hemophilia A with inhibitor patients receiving Hemlibra prophylaxis first patient dosed in phase 1/2 trial
GeneTx Biotherapeutics

Ultragenyx Pharmaceuticals
intrathecally administered GTX-102 Angelman syndrome clearance from Health Canada to initiate phase 1/2 trial
Xalud Therapeutics XT-150 patients with radicular neuropathic pain due to lumbar disc disease first patient dosed in phase 1/2a trial
Galera Therapeutics GC4711 in combination with stereotactic body radiation therapy (SBRT) locally advanced pancreatic cancer first patient dosed in phase 2b trial
Xalud Therapeutics XT-150 moderate-to-severe pain due to osteoarthritis of the knee recruitment complete in phase 2b trial
Endogena Therapeutics EA-2353 ophthalmic suspension retinitis pigmentosa Orphan Drug designation granted by the FDA
GammaDelta Therapeutics GDX012 acute myeloid leukemia Orphan Drug designation granted by the FDA
Bridge BioPharma BBP-631 congenital adrenal hyperplasia Fast-Track designation granted by the FDA
Palisade Bio LB1148 reduction of adhesions following abdominal or pelvic surgery Fast-Track designation granted by the FDA
Apellis Pharmaceuticals Empaveli (pegcetacoplan) adults with paroxysmal nocturnal hemoglobinuria approved by the FDA

 

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing